Clinical Trial

Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial

Study acronym: N6C
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated May 10, 2022 (before its estimated March 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Evaluate the efficacy and safety of neoadjuvant chemotherapy (NAC) with albumin-bound paclitaxel and carboplatin followed by chemoradiation therapy (CRT) for stage IIIC cervical cancer patients with carcinoma \>4 cm in greatest dimension and/or lymph node \>2cm in short axis.
Trial Details
NCT Number NCT05367206
Lead Sponsor Sun Yat-sen University
Conditions Cervical Cancer, Neoadjuvant Chemotherapy, Bulky Neoplasm
Enrollment 280 participants
Start Date 2022-03-14
Primary Completion 2024-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2022-05-10